|
|
| A well conceived Regulatory Framework is in place to approve GM crops and r-DNA products for human health based on independent appraisal and approval bodies to ensure high levels of human and environmental safety. A proactive government policy allows stem cell research in the country based on sound ethical guidelines. |
|
| The Indian Government is committed to a product patent regime by 2005 in total compliance with the provisions of WTO and TRIPS. While key aspects and relevant provisions of TRIPS, the Paris Convention and Doha declarations have been taken on board, available flexibilities have been incorporated to safeguard national security and protect varied interests of the nation including public health.
|
|
|
